Neurological Diseases

The Bascom Palmer Eye Institute at University of Miami Miller School of Medicine has received $4.7 million from NIH to create imaging techniques that will detect changes in capillary function and help diagnose cerebral small vessel disease.

The first subject has been dosed in a phase 1 clinical trial of an oral proteolysis-targeting chimera protein degrader to treat neurodegenerative diseases, according to the manufacturer.

A Houston-based neurohealth company has received a patent for its non-invasive, frequency-based deep brain stimulation device to address a range of psychiatric and neurologic conditions.

K2 Medical Research has partnered with Magruder Eye Institute and RetiSpec in a research pilot to improve access to clinical trials, using AI-driven technology to prescreen eligible candidates in an eye care setting.

Nido Biosciences has announced positive results from a phase 1 study of its novel, small molecule therapeutic to treat spinal and bulbar muscular atrophy in healthy male participants.

SAN DIEGO - Clinicians must rule out several neurological diseases that often mimic MS when making a diagnosis, according to a presenter at ACTRIMS 2023.

A team of three Ohio research companies has won a seat on an 8-year, $149 million indefinite delivery, indefinite quantity contract vehicle for the National Institute of Neurological Disorders and Stroke.

SEATTLE — COVID-19, caused by SARS-CoV-2 infection, is linked to a wide range of conditions that affect neurological processes, according to an expert at the 2022 American Academy of Neurology annual meeting.

The American Academy of Neurology noted palliative care can benefit individuals with neurologic diseases and may lead to longer survival when provided early in the disease process.

A study demonstrating that galantamine, a cholinesterase inhibitor, significantly reduced risk for severe dementia over a 5-year period among patients with Alzheimer’s led neurology coverage in April.